This updated advisory is a follow-up to the original advisory titled ICSMA-21-355-01 Fresenius Kabi Agilia Connect Infusion System that was published December 21, 2021, to the ICS webpage on www.cisa.gov/uscert. This advisory contains mitigations for several vulnerabilities in the Fresenius Kabi Agilia Connect Infusion System.

https://us-cert.cisa.gov/ics/advisories/icsma-21-355-01